Company attributes
B2X
CEO
AngelList URL
Pitchbook URL
Legal Name
TESARO, Inc.
Legal classification
Date Incorporated
March 26, 2010
Number of Employees (Ranges)
501 – 1,0000
Email Address
contact@tesarobio.com
Phone Number
+188882552490
+65623283380
+4420804750000
Full Address
Five Moore Drive North Carolina 27709-3398 USA0
23 Rochester Park Singapore 1392340
5 Crescent Drive Philadelphia PA 19112 United States0
980 Great West Road Brentford Middlesex TW8 9GS United Kingdom0
CIK Number
Place of Incorporation
Investors
DUNS Number
9633855590
IRS Number
272,249,6870
Founded Date
March 1, 2010
Total Funding Amount (USD)
457,000,000
Latest Funding Round Date
April 18, 2016
Stock Symbol
TSRO
Exchange
CFO
Former CEO
Acquisition Transaction
Latest Funding Type
CAGE Code
7G0C90
Patents Assigned (Count)
2
Wellfound ID
Country
Headquarters
Other attributes
Acquirer
Company Operating Status
Active
SIC Code
2,8340
Wikidata ID
Tesaro is a pharmaceutical company focused on oncology, founded in 2010. The company's research and design focuses on science related to the immune system, the use of human genetics, and advanced technologies. Tesaro also created programs to provide resources for people living with cancer, including women living with ovarian cancer, support for recurrent ovarian cancers, and other support programs for gynecological cancers.
Tesaro was acquired by GSK in 2019.
Timeline
No Timeline data yet.
